Summary
This prediction ended on 22.01.19 with a price of €33.38. The BUY prediction by melinda finished with a performance of 9.19%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| QIAGEN NV | - | - | - | - |
| iShares Core DAX® | -0.598% | 0.645% | 10.813% | 15.396% |
| iShares Nasdaq 100 | -3.290% | -4.193% | 23.772% | 40.773% |
| iShares Nikkei 225® | -0.796% | -0.582% | 8.390% | 8.288% |
| iShares S&P 500 | -1.164% | -0.857% | 23.003% | 41.152% |
According to melinda what are the pros and cons of QIAGEN NV for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread QIAGEN NV diskutieren
SecteurRecherche biotechnologique et médicale Agenda 22/11 Présentation
En 2017, le groupe développé plus de 500 produits consommables et solutions automatiques ont plus de 35 sites de production dans le monde.
La répartition géographique du CA est la suivante: Budget Unis (40,9%), Amérique (5,2%), Europe-Moyen Orient-Afrique (32,7%) et autres (21,2%).
Nombre d'employés : 4 688 personnes.